NCT01519752View on ClinicalTrials.gov

A Therapeutic Equivalence Study of Two Oxiconazole Nitrate Topical Cream Treatments for Patients With Tinea Pedis

PHASE1CompletedINTERVENTIONAL
Enrollment

661

Participants

Timeline

Start Date

November 30, 2011

Primary Completion Date

August 31, 2012

Study Completion Date

November 30, 2012

Conditions
Tinea Pedis
Interventions
DRUG

Oxiconazole Nitrate Cream 1%

Oxiconazole Nitrate Cream 1% applied to affected area once a day for 28 days

DRUG

Oxiconazole Nitrate Cream 1% (Oxistat®)

Oxiconazole Nitrate Cream 1%(Oxistat®)applied to affected area once a day for 28 days

DRUG

Placebo

Placebo applied to affected area once a day for 28 days

All Listed Sponsors
lead

Sun Pharmaceutical Industries, Inc.

INDUSTRY

NCT01519752 - A Therapeutic Equivalence Study of Two Oxiconazole Nitrate Topical Cream Treatments for Patients With Tinea Pedis | Biotech Hunter | Biotech Hunter